Skip to main content
  • Pharmaco-Invasive Strategy Provides Alternative for Older STEMI Patients Unable to Undergo Primary PCI, STREAM-2 Follow-Up Study Suggests

    A half-dose of tenecteplase shows similar outcomes to primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients who are 60 years of age or older, a new analysis shows.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details